An Integrated Algorithm for Differentiating Hypertrophic Cardiomyopathy From Hypertensive Heart Disease
Journal of Magnetic Resonance Imaging · 2023-10 · 58 (4) · 1084-1097
DOI: 10.1002/jmri.28580 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Magnetic Resonance Imaging, online erschienen am 23.01.2023. Verfasst von Ling-Cong Kong und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Renji Hospital, School of Medicine Shanghai Jiaotong University, Shanghai, China. Hauptthemen laut MEDLINE: Cardiomyopathy, Hypertrophic, Heart Diseases, Hypertension. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 40 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Background
Differentiating hypertrophic cardiomyopathy (HCM) from hypertensive heart disease (HHD) is challenging.
Purpose
To identify differences between HCM and HHD on a patient basis using MRI. Study Type Retrospective. Population A total of 219 subjects, 148 in phase I (baseline data and algorithm development: 75 HCM, 33 HHD, and 40 controls) and 71 in phase II (algorithm validation: 56 HCM and 15 HHD). Field Strength/Sequence Contrast‐enhanced inversion‐prepared gradient echo and cine‐balanced steady‐state free precession sequences at 3.0 T. Assessment MRI parameters assessed included left ventricular (LV) ejection fraction (LVEF), LV end systolic and end diastolic volumes (LVESV and LVEDV), mean maximum LV wall thickness (MLVWT), LV global longitudinal and circumferential strain (GRS, GLS, and GCS), and native T1. Parameters, which were significantly different between HCM and HHD in univariable analysis, were entered into a principal component analysis (PCA). The selected components were then introduced into a multivariable regression analysis to model an integrated algorithm (IntA) for screening the two disorders. IntA performance was assessed for patients with and without LGE in phase I (development) and phase II (validation). Statistical Tests Univariable regression, PCA, receiver operating curve (ROC) analysis. A P value
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiology, Renji Hospital, School of Medicine Shanghai Jiaotong University, Shanghai, China.
- Department of Radiology, Renji Hospital, School of Medicine Shanghai Jiaotong University, Shanghai, China.
- Department of Epidemiology and Biostatistics, West China School of Public Health, Sichuan University, Chengdu, China.
- Department of Cardiology, Shanghai Chest Hospital, Shanghai Jiao Tong University, Xuhui Distinct, Shanghai, China.
ORCID-Profile: Ling-Cong Kong
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Kong, L. C., Wu, L. M., Wang, Z., Liu, C., & He, B. (2023). An Integrated Algorithm for Differentiating Hypertrophic Cardiomyopathy From Hypertensive Heart Disease. Journal of Magnetic Resonance Imaging, 58(4), 1084-1097. https://doi.org/10.1002/jmri.28580
Vancouver
Kong LC, Wu LM, Wang Z, Liu C, He B. An Integrated Algorithm for Differentiating Hypertrophic Cardiomyopathy From Hypertensive Heart Disease. Journal of Magnetic Resonance Imaging. 2023;58(4):1084-1097. doi:10.1002/jmri.28580
BibTeX
@article{Kong2023,
author = {Kong, Ling-Cong and Wu, Lian-Ming and Wang, Zi and Liu, Chang and He, Ben},
title = {An Integrated Algorithm for Differentiating Hypertrophic Cardiomyopathy From Hypertensive Heart Disease},
journal = {Journal of Magnetic Resonance Imaging},
year = {2023},
volume = {58},
number = {4},
pages = {1084--1097},
doi = {10.1002/jmri.28580}
}
EUVIMED